ovarian cancer: coverage of parp inhibitors
Published 6 years ago • 148 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
6:36
role of parp inhibition in ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
6:20
parp inhibitors in recurrent ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
3:45
parp inhibitors for ovarian cancer
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
0:59
the evolution of parp inhibitors in ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
1:05:05
the changing role of parp inhibitors in the treatment of ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
6:14
standard of care and progress with parp inhibitors for ovarian cancer
-
3:25
ovarian cancer: recurrence after parp inhibition
-
0:46
parp inhibitor rechallenging in ovarian cancer